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Granzyme B Directly and Efficiently Cleaves
Several Downstream Caspase Substrates:
Implications for CTL-Induced Apoptosis
specific proteolytic cleavage after aspartic acid for acti-
vation (reviewed by Nicholson and Thornberry, 1997).
Granzyme B, a serine protease found in the cyto-
plasmic granules of cytotoxic T lymphocytes (CTL) and
natural killer cells, has a similar requirement for aspartic
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have indicated that the cleavage of poly(ADP-ribose)
polymerase (PARP), U1-70 kDa, and lamin B observedSummary
during granzyme B±induced cell death is catalyzed by
caspases, rather than directly by granzyme B (DarmonCaspase-mediated proteolysis of downstream sub-
et al., 1995; Talanian et al., 1997), but the effects ofstrates is a critical element of the execution pathway
granzyme B on other caspase substrates in vitro andcommon to all forms of apoptosis studied to date.
during granule-induced cytotoxicity have not been ex-While this caspase-dependent pathway is activated
tensively studied.during cytotoxic lymphocyte granule±induced cell death,
In the study presented in this report, we demonstraterecent studies have also provided evidence for cas-
that the DNA-dependent protein kinase catalytic sub-pase-independent pathways. However, the mecha-
unit (DNA-PKcs) and nuclear mitotic apparatus proteinnisms mediating these additional pathways have not
(NuMA) are directly cleaved by granzyme B, both in vitrobeen defined. The current study demonstrates that
and in cells undergoing granule-induced cytotoxicity.DNA-PKcs and NuMA are directly and efficiently cleaved Although the efficiency of cleavage of these substratesby granzyme B in vitro and in vivo, generating unique
is similar to that observed for caspase 3±mediated cleav-substrate fragments not observed during other forms
age, the fragments generated by the two proteases areof apoptosis. This direct, caspase-independent ability
distinct. Since caspases initiate apoptosis by alteringof granzyme B to cleave downstream death substrates
the function of downstream substrates (either by de-constitutes an apoptotic effector mechanism that is
creasing the function of the intact substrate or by gener-insensitive to inhibitors of the signaling or execution
ating fragment[s] with pro-apoptotic activity), it is likelycomponents of the endogenous apoptotic cascade.
that direct cleavage of caspase substrates by granzyme
B during cytotoxic lymphocyte granule±induced apopto-
sis plays an important role in caspase-independent tar-
Introduction get cell death. This ability of the contents of cytotoxic
lymphocyte granules to bypass the requirement for cas-
Apoptosis is a morphologically and biochemically dis- pases in the death pathway may guarantee the demise
tinct form of cell death that occurs in many different cell of target cells whose caspase pathway is incomplete
types during a wide range of physiologic and pathologic or under strict endogenous or exogenous regulatory
circumstances (reviewed by Thompson, 1995; White, control.
1996; Jacobson et al., 1997). Recent studies have estab-
lished that specific proteolysis catalyzed by a novel fam-
Resultsily of cysteine proteases is of critical importance in medi-
ating apoptosis (reviewed by Salvesen and Dixit, 1997).
DNA-PKcs and NuMA Are Very EfficientThese proteases, termed ªcaspasesº, which cleave
Substrates for Purified Granzyme Bdownstream substrates after a consensus tetrapeptide
Granzyme B has previously been shown to cleave thesequence ending with aspartic acid (P1), are synthe-
precursors of several caspases (including caspases 3,sized as inactive precursors that themselves require
7, and 10), resulting in activation of their proteolytic
activity. The catalytic efficiency of cleavage of these
substrates by granzyme B serves as a useful standard7 To whom correspondence should be addressed (e-mail: lcasciol@
welchlink.welch.jhu.edu and arosen@welchlink.welch.jhu.edu). against which granzyme B±mediated cleavages of other
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substrates known to be cleaved by caspases during
apoptosis were also directly cleaved by granzyme B,
and compared the efficiency of cleavage of each sub-
strate by the two proteases. Purified DNA-PKcs was very
efficiently cleaved by granzyme B in the absence of
added DNA (kcat/Km 5 2.5 6 0.8 3 106 M21s21; Figure 1
and Table 1), making it the best substrate for granzyme
B described to date, with a cleavage efficiency two or-
ders of magnitude better than that described for gran-
zyme B±mediated cleavage of the caspase-3 precursor.
When similar experiments were performed in the pres-
ence of 10 mg/ml DNA, DNA-PKcs cleavage was de-
creased by approximately 90% (data not shown).
Caspase-3±mediated cleavage of DNA-PKcs was also
extremely efficient (kcat/Km value 5 7.5 6 0.8 3 106
M21s21); in this case, efficient cleavage was obtained
only in the presence of DNA (Casciola-Rosen et al., 1995)
(Table 1). NuMA, a nuclear matrix protein that is cleaved
in apoptotic cells by an unidentified caspase family
member, was also very efficiently cleaved by granzyme
B (kcat/Km 5 5.4 6 1.4 3 105 M21s21; Table 1). The effi-
ciency of this cleavage was one order of magnitude
greater than that observed for granzyme B±mediated
processing of the caspase-3 precursor. NuMA was also
efficiently cleaved by purified caspase-3, with a kcat/Km
value of 5.0 6 1.0 3 105 M21s21 (Table 1). In contrast
to DNA-PKcs and NuMA (for which granzyme B± and
caspase-3±mediated cleavages are similarly efficient),
PARPwas a poor substrate for granzyme B, with a kcat/Km
value (2.3 6 1.8 3 104 M21s21) approximately 200-fold
lower than that for caspase-3 (Table 1). Granzyme B
was also a poor catalyst for cleaving U1-70 kDa, with a
kcat/Km value of less than 103 M21s21 (data not shown).
Different Substrate Fragments Are Detected
after Cleavage of Autoantigens In Vitro
with Granzyme B versus Caspase-3Figure 1. Granzyme B Cleaves Purified DNA-PKcs, NuMA, PARP,
To compare directly the fragments generated by gran-and Caspases-3 and -7 In Vitro with Different Efficiencies
zyme B and caspase-3, purified DNA-PKcs, in vitro±Cleavage reactions contained 0±12.5 nM granzyme B (for DNA-PKcs
and NuMA) or 0±50 nM granzyme B (for caspases-3 and -7 and translated [35S]methionine-labeled PARP, and endoge-
PARP). Cleavage fragments were detectedby fluorography or immu- nous substrates (NuMA and DNA-PKcs in HeLa cell
noblotting (monoclonal antibody 18-2 was used to detect DNA- lysates) were incubated with protease and electropho-
PKcs); the SDS-PAGE migration positions of the intact molecules resed in adjacent gel lanes. When granzyme B was used
(arrows) and the fragment sizes are indicated. Experiments were
to cleave DNA-PKcs, fragments of 100 and 250 kDa wereperformed on two (caspase-7), three (PARP, NuMA, and DNA-PKcs),
generated (detected by immunoblotting using antibod-or four (caspase-3) separate occasions and produced similar re-
sults. ies recognizing the C-terminus or N-terminus of DNA-
PKcs, respectively) (Figure 2, lanes 2 and 5). In contrast,
caspase-3 cleavage yielded a 150 kDa C-terminal frag-
ment (Figure 2, lane 3) and a 250 kDa N-terminal frag-substrates can be compared. Purified [35S]methionine-
labeled precursors of caspase-3 and caspase-7 or THP.1 ment (Figure 2, lane 6). Granzyme B±mediated cleavage
of NuMA generated a novel fragment migrating at 175cytosols (containing these precursor proteases) were
incubated in vitro with increasing concentrations of kDa on sodium dodecyl sulfate (SDS)±polyacrylamide
gel electrophoresis (PAGE), which was distinct from thepurified granzyme B. The dose±response data obtained
(Figure 1 and data not shown) were used to calculate 185 kDa fragment detected after cleavage with cas-
pase-3 (Figure 2, lanes 7±9). Similarly, novel fragmentscatalytic constant (kcat/Km) values of 1.8 6 0.6 3 105
M21s21 (radiolabeled substrate) and 1.9 6 0.1 3 105 of PARP migrating at 72, 62, and 42 kDa were detected
after incubation with granzyme B; these differed fromM21s21 (immunoblot) for caspase-7, and 3.6 6 1.0 3
104 M21s21 (radiolabeled substrate) and 2.3 6 0.4 3 104 the 89 and 24 kDa fragments generated by caspase-
3±mediated cleavage of PARP (Figure 2, lanes 10±12).M21s21 (immunoblot) for caspase-3 (Table 1 and data
not shown). Granzyme B therefore directly cleaves several of the
downstream substrates of caspase-3 in vitro; in allWe next addressed whether any of the downstream
Granzyme B±Mediated Cleavage of Caspase Substrates
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Table 1. Comparison of Catalytic Constant Values for the Cleavage of Different Substrates by Granzyme B and Caspase-3
kcat/Km (M21s21)
Cleavage by Cleavage by
Substrate Method of Detection Granzyme B Caspase-3
DNA-PKcs Immunoblotting 2.5 6 0.8 3 106 7.5 6 0.8 3 106
NuMA Fluorography 5.4 6 1.5 3 105 5.0 6 1.0 3 105
Caspase-7a Fluorography 1.8 6 0.6 3 105 Ð
Caspase-7b Immunoblotting 1.9 6 0.6 3 105 Ð
Caspase-3 Fluorography 3.6 6 1.0 3 104 Ð
Caspase-3 Immunoblotting 2.3 6 0.4 3 104 Ð
PARP Fluorography 2.3 6 1.8 3 104 5.0 6 0.2 3 106
The data obtained in time-course experiments were densitometrically scanned and used to calculate the percentage cleavage of each
substrate. These values were fitted to the first-order rate equation [% substrate cleaved 5 100 3 (1 2 e2kcat3[E]/Km3time)] to calculate kcat/Km.
Measurements for each protease±substrate combination were performed at three different protease concentrations, enabling experimental
variations in kcat/Km to be assessed.
a All substrates detected by fluorography were [35S]methionine labeled using coupled in vitro transcription and translation from the appropriate
cDNAs.
b The source of caspase-3 and -7 precursors used in immunoblotting was THP.1 cytosol. Blotting antibodies were specific for either caspase-3
or -7, respectively.
cases, the fragments generated by granzyme B differ Granzyme B Induces Novel Fragments of DNA-PKcs
and NuMA in Cell Lysatesfrom those generated by caspase-3.
Previous studies have demonstrated that the cleavage
of PARP that occurs in lysates of COS cells expressing
Kinase Activity of DNA-PKcs Is Abolished granzyme B can be almost completely inhibited by the
by Granzyme B Cleavage caspase inhibitor Ac-DEVD-CHO (N-[N-Ac-Asp-Glu-Val]-
To address the effect of granzyme B±mediated cleavage 3-amino-4-oxobutanoic acid) (Darmon et al., 1995).
on the kinase activity of DNA-PKcs, we quantitated the Since this compound is not an inhibitor of granzyme B,
ability of intact and cleaved DNA-PKcs to phosphorylate this observation suggests that this cleavage is mediated
the SP1 transcription factor. As described previously, solely by caspases that have been activated by gran-
the kinase activity of DNA-PK was entirely DNA-depen- zyme B in these extracts. The observation that PARP
itself is cleaved by granzyme B approximately 200-folddent (Figure 3A, lanes 1 and 2). When DNA-PKcs was
pretreated with 12.5 nM granzyme B for 13.5 min at 378C less efficiently than by caspase-3 further supports this
conclusion (Table 1).to cleave DNA-PKcs, followed by the addition of DNA,
[g32P]ATP, and SP1 (which initiate the phosphorylation Since NuMA and DNA-PKcs are cleaved with similar
efficiencies by caspase-3 and granzyme B, it was ofreaction), kinase activity was entirely abolished (Figure
3A, lane 3). Whether any of the fragments generated by interest to determine whether these substrates are
cleaved directly by granzyme B in cell lysates that con-granzyme B±mediated cleavage of DNA-PKcs have novel
activity(ies) remains to be determined. tain caspase precursors. We therefore established an
Figure 2. Cleavage of Autoantigens In Vitro
with Purified Granzyme B or Caspase-3 Yields
Different Fragments
Reactions containing 30 nM purified DNA-
PKcs (lanes 1±3), endogenous DNA-PKcs and
NuMA in HeLa lysate (lanes 4±9),or [35S]meth-
ionine-labeled PARP (lanes 10±12) were incu-
bated with the following concentrations of
granzyme B: 1.25 nM (lane 2), 12.5 nM (lanes 5
and8), or50 nM (lane 11). Similar experiments
were performed with these substrates using
caspase-3 at 42 pM (lanes 3 and 12) or 100
pM (lanes 6 and 9). Reaction mixtures were
incubated at 378C for 15 min (granzyme B
reactions) or 60 min (caspase-3 reactions).
Note that 100 nM Ac-DEVD-CHO was added
when granzyme B was used to cleave DNA-
PKcs and NuMA in HeLa cell lysates, to pre-
vent activation of HeLa cell caspases. Intact
and cleaved NuMA and DNA-PKcs were visu-
alized by immunoblotting, and PARP was visualized by autoradiography. DNA-PKcs was blotted using monoclonal antibodies 25-4 (directed
against the C-terminus; lanes 1±3) and 18-2 (directed against the N-terminus; lanes 4±6). Similar results were obtained in eight other experiments.
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Figure 3. Granzyme B Cleaves DNA-PK at Two Different Sites and
Abolishes Kinase Activity Figure 4. Endogenous DNA-PKcs and NuMA in HeLa Cell Lysates
(A) Kinase activity of DNA-PK is abolished after cleavage with gran- Are Cleaved in a Caspase-Independent Manner
zyme B. Kinase assays were performed using intact DNA-PK (lanes In this experiment, 12.5 nM purified granzyme B (lanes 5±7) or 105
1 and 2) or granzyme B±cleaved DNA-PK (lanes 3 and 4) in the pM purified caspase-3 (lanes 2±4) was added to lysates of control
absence (lanes 2 and 4) or presence (lanes 1 and 3) of 10 mg/ml HeLa cells in the presence of 100 nM Ac-DEVD-CHO (lanes 3 and
DNA. DNA-PK itself was omitted from the otherwise complete kinase 6) or 100 nM Ac-YVAD-CHO (lanes 4 and 7). After incubation at 378C
reaction mixture as a control in lane 5. Phosphorylation of SP1 for 60 min, the reactions were terminated. DNA-PKcs, NuMA, and
substrate was detected by autoradiography. Results are representa- PARP were detected by immunoblotting (monoclonal antibody 18-2
tive of three separate experiments. was used to detect DNA-PKcs). Equal amounts of protein were elec-
(B) Granzyme B cleaves DNA-PKcs at VGPD2698-F2699 and trophoresed in each lane. Data from a representative experiment
DEVD2712-N2713. A [35S]methionine-labeled wild-type (wt) DNA- are shown; similar data were obtained in five other experiments.
PKcs polypeptide (DNA-PK2566±2928) and two radiolabeled poly-
peptides containing mutations in the P1 positions of the predicted
granzyme B cleavage site (D2698A) and the known caspase-3 cleav-
kDa), and DNA-PKcs (250 kDa N-terminal fragment andage site (D2712A) were generated. These polypeptides were incu-
150 kDa C-terminal fragment) were generated (Figure 4,bated in the absence of added proteases (lanes 1, 4, and 7) or in
the presence of 8 nM recombinant caspase-3 (lanes 2, 5, and 8) or lane 2 and data not shown). As demonstrated previously,
8 nM purified granzyme B (lanes 3, 6, and 9) for 60 min at 378C. substrate fragments generated by the activity of cas-
After termination of the reactions, samples were electrophoresed pase-3 were entirely abolished by 100 nM Ac-DEVD-
and the intact polypeptide and the cleavage products weredetected
CHO (Ki caspase-1 5 17 nM; Ki caspase-3 5 0.2 nM; Kiby fluorography. Fragment sizes of 18 (a), 28 (b), 20 (c), and 26 (d)
caspase-6 5 31 nM; Ki caspase-7 5 1 nM; Ki cas-kDa were generated. A schematic representation of these results
pase-8 5 0.92 nM ; Ki caspase-9 5 60 nM; and Kiis shown (bottom).
caspase-10 5 12 nM) (Figure 4, lane 3), but were unaf-
fected by 100 nM Ac-YVAD-CHO (N-[N-Ac-Tyr-Val-Ala]-
3-amino-4-oxobutanoic acid) (Ki caspase-1 5 0.6 nM;in vitro assay system in which cleavage of endogenous
DNA-PKcs, NuMA, or PARP was monitored after addition Ki caspase-3 and Ki caspase-7 .10 mM; and Ki cas-
pase-10 5 408 nM) (Figure 4, lane 4). In the presence ofof purified caspase-3 or granzyme B in the presence or
absence of Ac-DEVD-CHO. Incubation of control ex- 12.5 nM granzyme B, all three substrates were efficiently
cleaved (Figure 4, lane 5).tracts at 378C for 60 min resulted in no significant cleav-
age of DNA-PKcs or PARP, but was associated with As shown previously, the predominant PARPfragment
induced by granzyme B comigrated with the fragmentminimal cleavage of NuMA, which generated minor frag-
ments of 185 and 187 kDa (Figure 4, lane 1). When induced by caspase-3 (Figure 4, lane 5); there was also
a minor (,5%) fragment of 62 kDa that correspondedpurified caspase-3 was added to control extracts, cas-
pase-3±specific fragments of PARP (89 kDa), NuMA (185 with the fragment induced by granzyme B on purified
Granzyme B±Mediated Cleavage of Caspase Substrates
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substrate (data not shown). In contrast, only a minor cleavage was entirely abolished by the D2712A mutation
(Figure 3B, lanes 7 and 8), confirming that caspase-3proportion of the NuMA fragments induced by granzyme
B comigrated with the fragment generated by cas- cleaves at DEVD2712±N2713. In addition to fragments
identical to those generated by caspase-3, granzyme Bpase-3 (185 kDa); the major, novel fragment of 175 kDa
(Figure 4, lane 5) corresponded with the fragment in- cleavage also produced fragments of 28 kDa and 18
kDa (Figure 3B, lane 3); these unique fragments wereduced by granzyme B on purified in vitro±translated
substrate (data not shown). Granzyme B±mediated enhanced by the D2712A mutation, but were abolished
by the D2698A mutation (Figure 3B, lanes 6 and 9).cleavage of DNA-PKcs generated a 250 kDa N-terminal
fragment comigrating with that generated by caspase-3 These data demonstrate that granzyme B can cleave at
VGPD2698±F2699, a site predicted by previous studies(Figure 4, lanes 2 and 5), as well as a unique 100 kDa
C-terminal fragment (data not shown) that corresponded using a combinatorial tetrapeptide substrate library
(Thornberry et al., 1997). Furthermore, granzyme B alsowith that induced by granzyme B on purified substrate
(Figure 2, lane 2). cleaves at the caspase-3 cleavage site, DEVD2712±
N2713. The C-terminal granzyme B±unique cleavageWhen Ac-DEVD-CHO or 2 mM iodoacetamide was
added to the extracts 15 min before addition of gran- site, which generates the 100 kDa fragment, remains to
be defined.zyme B, cleavage of PARP was almost entirely abolished
(Figure 4, lane 6 and datanot shown). In striking contrast,
the cleavage of NuMA and DNA-PKcs was only partially Granzyme B±Specific Fragments of DNA-PKcs andinhibited (Figure 4, lane 6 and data not shown; 20%±40% NuMA Are Generated during Cytotoxic
inhibition in five separate experiments). Generation of Lymphocyte Granule±Induced
caspase-3±specific fragments of both NuMA (185 kDa) Target Cell Death
and DNA-PKcs (150 kDa C-terminal fragment; data not To address whether the granzyme B±specific substrate
shown) was abolished under these circumstances, while fragments demonstrated in cell lysates also appear dur-
formation of the 250 kDa N-terminal fragment of DNA- ing granule-induced cytotoxicity, we examined sub-
PKcs was inhibited by 20%±40% (Figure 4, lane 6). In strate cleavage during granule content±induced target
contrast, generation of granzyme B±specific fragments cell death. When several different target cells (Jurkat
(175 kDa NuMA fragment and 100 kDa C-terminal DNA- T cells, K562 erythroleukemia cells, human myoblasts,
PKcs fragment) was not affected (Figure 4, lane 6 and or HeLa cells) were incubated with granule contents
data not shown). The failure of Ac-DEVD-CHO to mark- (z1.5 3 107 YT cell equivalents/ml) in the presence of
edly inhibit generation of the 250 kDa DNA-PKcs frag- Ca21, rapid target cell lysis was induced (achieving
ment confirms that the majority of DNA-PKcs cleavage z20%±40% specific 51Cr release in 60 min). As pre-
detected after addition of granzyme B to lysates results viously described, target cell lysis by granule contents
from direct cleavage by this protease (rather than indi- did not occur in the absence of Ca21 (Podack and
rectly through activation of caspase-3). Konigsberg, 1984). DNA-PKcs, NuMA, and PARP all wereTaken together, these data demonstrate that gran- cleaved rapidly after addition of granules, in a Ca21-
zyme B competeswith caspase-3 for cleavage of endog- dependent manner (Figure 5A, lanes 2 and 3). As ob-
enous substrates in cell lysates. The outcome of this served in HeLa lysates (Figure 4), cleavage of PARP
competition can be accurately predicted by comparing resulted almost completely in the generation of the 89
kcat/Km values: for those substrates where the kcat/Km for kDa caspase-3±specific fragment (Figure 5A, lane 3);
cleavage by caspase-3 is greater than that for cleavage only small amounts of the 62 kDa granzyme B±specific
by granzyme B (e.g., PARP), caspase-3 fragments are fragment were generated (data not shown). Generation
detected almost exclusively. For those substrates where of the 89 kDa fragment was completely inhibited by
the kcat/Km values are similar for the proteases, addition Ac-DEVD-CHO (Figure 5A, lane 4). In contrast, granule
of granzyme B results in the formation of novel, gran- contents induced the formation of granzyme B±specific
zyme B±specific fragments (e.g., DNA-PKcs and NuMA). cleavage fragments of DNA-PKcs and NuMA (Figure 5A,
lane 3); these were not inhibited by Ac-DEVD-CHO (Fig-
ure 5A, lane 4). In the case of DNA-PKcs, addition ofGranzyme B Cleavage Sites in DNA-PKcs granule contents also resulted in the formation of smallTo determine whether the 250 kDa DNA-PKcs fragment amounts of 150 and 120 kDa fragments, which were wellgenerated by caspase-3 and granzyme B result from
visualized only after longer exposures of the x-ray film;cleavage at the same or at different but closely spaced
generation of these fragments was entirely inhibited bysites, not distinguishable by SDS-PAGE, we generated
Ac-DEVD-CHO (data not shown).a fragment of DNA-PKcs (Met2566±Leu2928) encom-
passing both the known caspase-3 cleavage site at
DEVD2712±N2713 (Casciola-Rosen et al., 1996; Song et Granzyme B±Specific Fragments of DNA-PKcs and
NuMA Are Generated in Fas-Negative Targetal., 1996b) as well as the potential granzyme B cleavage
site at VGPD2698±F2699. The relevant P1 aspartic acids Cells Attacked by Lymphokine-Activated
Killer Cells(D2698 and D2712) in this fragment were mutated to
alanines (D2698A and D2712A), and susceptibility of To address whether granzyme B±specific fragments
were generated during lymphocyte-induced cytotoxic-wild-type and mutated forms to cleavage by caspase-3
or granzyme B was assessed (Figure 3B). Cleavage of ity, we used the Fas-negative cell line K562 as a target
for lymphokine-activated killer (LAK) cells (Topalian etthe wild-type protein by caspase-3 resulted in two frag-
ments, 26 and 20 kDa (Figure 3B, lanes 1 and 2); this al., 1989; McGahon et al. 1995). To permit biochemical
Immunity
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Figure 5. Granzyme B±Specific Fragments
Are Generated during Cytotoxicity In Vivo
(A) Endogenous DNA-PKcs, NuMA, and PARP
are cleaved after in vivo incubation of intact
K562 cells with YT cell granule contents. K562
cells were incubated for 30 min at 378C in the
absence (lanes 1±3) or presence (lane 4) of
100 mM Ac-DEVD-CHO. Aliquots of these cell
suspensions (each containing 3.4 3 105 K562
cells) were then incubated for an additional
90 min at 378C in the presence of 1 mM Ca21
(lane 1), 1 mM EDTA plus YT cell granule con-
tents (lane 2), or 1 mM Ca21 plus YT cell gran-
ule contents (lanes 3 and 4). After termination
of the reactions, DNA-PKcs, NuMA, and PARP
were detected by immunoblotting. Data are
representative of four similar experiments.
(B) Granzyme B±specific fragment of DNA-
PKcs is generated in K562 cells attacked by
LAK cells. Fas-negative K562 target cells
were preincubated in the absence (lanes 1±3)
or presence (lane 4) of 100mM Ac-DEVD-CHO
for 1 hr, followed by coincubation with LAK
cells for an additional 4 hr at 378C (ef-
fector:target ratio of 5:1). After termination of
the reactions, the following numbers of cells were electrophoresed in each gel lane: 6.5 3 105 LAK cells (lane 5); 1.3 3 105 K562 cells (lane
6); and 6.5 3 105 LAK cells plus 1.3 3 105 K562 cells (lanes 7 and 8). DNA-PKcs and PARP were detected by immunoblotting. Similar data
were obtained using three different preparations of LAK cells.
analysis of cleaved proteins in target cells, an ef- whether these granules induced any morphologic target
cell changes under these conditions. HeLa cells werefector:target cell ratio of 5:1 was used. The signature
89 kDa caspase-3 fragment of PARP was generated preincubated with YT cell granule contents in the pres-
ence or absence of 200 mM Ac-DEVD-CHO, prior toduring LAK-induced target cell death (Figure 5B, lane
7); PARP cleavage was entirely abolished by 100 mM Ac- addition of Ca21 and further incubation at 378C for 60
min. YT cell granule contents induced the rapid onsetDEVD-CHO (Figure 5B, lane 8), consistent with results
observed when target cell death was initiated with YT (,60 min) of prominent surface blebbing (Figure 6A),
followed by nuclear condensation and fragmentationcell granule contents (Figure 5A, lane 4). Using anti±
C-terminal antibodies, both the 100 kDa granzyme into membrane-bound apoptotic bodies (Figure 6B). As
we have described previously for ultraviolet B±inducedB±specific fragment of DNA-PKcs and the 150 kDa cas-
pase-3±specific fragment were generated during LAK- apoptosis (Casciola-Rosen et al., 1994), the autoanti-
gens targeted in systemic autoimmune diseases are rap-induced target cell death (Figure 5B, lane 7). In addition,
a 120 kDa fragment was observed in these cells, consis- idly redistributed in target cells exposed to YT cell gran-
ule contents, such that they become clustered aroundtent with the caspase-3±mediated cleavage of DNA-PKcs
at DWVD-G previously observed both in vitro and in the rim of the condensing apoptotic nucleus (Figure
6A) and then ultimately around apoptotic bodies (Figureintact cells (Casciola-Rosen et al., 1996; Song et al.,
1996b). While 100 mM Ac-DEVD-CHO inhibited the gen- 6B). Granule content±induced surface blebbing, nuclear
fragmentation, formation of apoptotic bodies, and char-eration of caspase-3±specific fragments of DNA-PKcs
by more than 90%, the 100 kDa granzyme B±specific acteristic redistribution of nuclear autoantigens were
prevented by Ac-DEVD-CHO (compare Figures 6B andfragment was insensitive to this inhibitor (Figure 5B, lane
8). These data are consistent with those obtained after 6C). However, a prominent diminution in the size of the
nucleus (which was accompanied by condensation ofinitiation of target cell death with YT cell granule con-
tents (Figure 5A, lane 4 and data not shown). Similar chromatin) was induced by granule contents in Ac-
DEVD-CHO±treated cells (Figure 6C); these nuclearobservations were made for the granzyme B±specific
NuMA fragment (data not shown). These data confirm changes were not observed when cells were incubated
with Ac-DEVD-CHO alone (data not shown).that the novel fragments of DNA-PKcs and NuMA defined
in these studies are indeed generated when intact lym-
phocytes induce target cell cytotoxicity using the gran- Discussion
ule pathway.
Recent studies using caspase inhibitors have empha-
sized the contribution of caspase-independent path-Cytotoxic Lymphocyte Granules Induce Nuclear
Morphologic Changes: Effects way(s) when target cell death is induced by cytotoxic
lymphocyte granule exocytosis (Sarin et al., 1997; Talan-of Caspase Inhibitors
Since several of the downstream substrates for the cas- ian et al., 1997). The study reported here demonstrates
that several of the downstream substrates for the cas-pases are directly and efficiently cleaved by granzyme
B during lymphocyte granule±induced cytotoxicity even pase family of proteases during apoptosis are also di-
rectly and efficiently cleaved by granzyme B both inin the presence of caspase inhibitors, we addressed
Granzyme B±Mediated Cleavage of Caspase Substrates
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Figure 6. Ac-DEVD-CHO±Insensitive Nuclear Morphologic Changes Are Induced in Intact HeLa Cells after In Vivo Incubation with YT Cell
Granule Contents
HeLa cells were incubated with YT cell granule contents for 1 hr at 378C in the absence (A and B) or presence (C) of 100 mM Ac-DEVD-CHO.
After fixation and permeabilization, cells were stained with antibodies to PARP, as well as propidium iodide (PI) and DAPI. Antibody staining
was visualized with fluorescein isothiocyanate±goat anti-human antibodies. Shown are merged images of antibody staining (green), PI staining
(red), and DAPI staining (blue).
(A and B) YT cell granule contents induce prominent PI-rich surface blebs, nuclear condensation, and fragmentation, with a characteristic
redistribution of PARP to the rim of the condensing nucleus (A) or apoptotic bodies (B, arrow).
(C) Granule contents induce marked nuclear condensation even in the presence of Ac-DEVD-CHO (arrows); an adjacent, normal HeLa cell
nucleus that has not yet undergone morphologic change is shown for comparison (arrowhead). Treatment with Ac-DEVD-CHO abolishes the
formation of PI-rich surface blebs, nuclear fragmentation, and the redistribution of PARP.
Size bar: A, 4.4 mm; B, 4.0 mm; C, 6.6 mm. Similar results were obtained in three separate experiments.
vitro and in target cells undergoing lymphocyte granule± forms of apoptosis. This is supported by the demonstra-
tion that the cleavage of DNA-PKcs by granzyme B com-induced cytotoxicity, confirming the existence of effi-
cient caspase-independent proteolytic pathways during pletely abrogates its kinase activity (Figure 3A). This
granzyme B±mediated cleavage of DNA-PKcs differsthis form of cell death.
Not all downstream substrates of caspase-3 are from caspase-3±mediated cleavage of this substrate in
several ways. First, the presence of DNA ends renderscleaved by granzyme B with similar efficiency. In the
case of PARP and U1-70 kDa, cleavage efficiency by the granzyme B±mediated cleavage significantly less
efficient, while DNA ends are required for efficient cleav-caspase-3 exceeds that by granzyme B by more than
200-fold, whereas NuMA and DNA-PKcs are cleaved by age of DNA-PKcs by caspase-3 (Casciola-Rosen et al.,
1996; Song et al., 1996b). Second, while caspase-3granzyme B and caspase-3 with similar efficiencies (Ta-
ble 1). The relative cleavage efficiency of a given sub- cleavage of DNA-PKcs decreases its kinase activity to
approximately 60% of control levels (Casciola-Rosen etstrate by the two proteases appears to account for the
results observed when caspase-3 activity is inhibited al., 1996), cleavage by granzyme B completely abro-
gates kinase activity. These data suggest that granzymein intact cells. Thus, whereas PARP cleavage during
granule-mediated cytotoxicity is inhibited by Ac-DEVD- B might cleave and fully inactivate DNA-PKcs very early
during granule-mediated cytotoxicity, before significantCHO, DNA-PKcs and NuMA cleavage are affected only
minimally. It is likely that caspase-independent compo- internucleosomal DNA cleavage has occurred (and thus
before caspase-3 can efficiently cleave DNA-PKcs). Oncenents of granule-mediated death are generated through
alteration of the function of the downstream substrates abundant DNA ends have been generated, it is likely
that cleavage by caspase-3 will predominate (with thethat granzyme B (and potentially other granule prote-
ases) efficiently cleaves. resulting fragments possessing residual kinase activity).
Although the functional consequences of substrateThe data reported here are consistent with those of
recent studies in which granzyme B±induced proteolysis cleavage by caspases during apoptosis in vivo is not
known for most substrates, recent data demonstrateof PARP and U1-70 kDa (both inefficient direct sub-
strates for granzyme B) in an intact cell model was well that cleavage can activate critical pro-apoptotic activi-
ties (e.g., activation of DNA fragmentation factor by cas-inhibited by caspase inhibitors (Talanian et al., 1997).
The results differ from those of a previous study of the pase-3 [Liu et al., 1997]). In other cases, data suggest
that substrate cleavage might disable important struc-cleavage of DNA-PKcs during CTL-induced target cell
death, as well as by granzyme B in vitro, that failed tural and homeostatic functions (Casciola-Rosen et al.,
1996). It is likely that the ability of cytotoxic lymphocyteto demonstrate unique DNA-PKcs fragments in either
setting (Song et al., 1996a). Different antibodies to DNA- granule proteases to directly cleave some caspase sub-
strates underlies the caspase-independent componentPKcs used in the two studies may account for the failure
of the previous study to demonstrate the unique 100 of the death pathway induced by these cells (Sarin et
al., 1997). The ability of the lymphocyte granule±inducedkDa C-terminal fragment generated by granzyme B.
The direct and efficient cleavage of NuMA and DNA- cytotoxicity pathway to generate a novel form of nuclear
condensation even in the absence of caspase activityPKcs by granzyme B may achieve functional effects simi-
lar to those caused by caspase cleavage during other is consistent with this proposal.
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Recent studies on macromolecular and tetrapeptide Rosen et al., 1994b, 1995, 1996; Casiano et al., 1996).
The observation here that several of these substratessubstrates have begun to provide insights into the sub-
strate specificity of granzyme B. For example, the direct are also directly cleaved by granzyme B, generating
unique fragments not generated during any other formcleavage of PARP by granzyme B occurs at VGPD537±
S538 (Froelich et al., 1996a), while the processing of of apoptosis studied thus far, suggests that nontolerized
determinants of autoantigens might be revealed duringseveral caspase precursors occurs at IETD sites (re-
viewed by Thornberry et al., 1997). The current study certain forms of CTL-mediated apoptotic death. Studies
are presently underway to determine whether the gener-demonstrates that granzyme B cleaves a macromolecu-
lar substrate (DNA-PKcs) at VGPD±F, a site consistent ation of novel fragments during CTL-mediated death is
a feature that unifies autoantigens.with the tetrapeptide substrate specificity of granzyme
B defined using a combinatorial tetrapeptide library
Experimental Procedures(Thornberry et al., 1997). Interestingly, granzyme B also
directly cleaves this substrate at a nearby DEVD±N, sug-
Materialsgesting that the determinants of macromolecular sub-
Purified DNA-PK and SP1 were purchased from Promega (Madison,
strate specificity are more complex than those con- WI). ATP was purchased from Fluka (Ronkonkoma, NY), and [32P]ATP
tained in the tetrapeptides tested. Using the fragment was from DuPont/NEN (Wilmington, DE). Ac-DEVD-CHO and Ac-
sizes of NuMA and DNA-PKcs generated by granzyme YVAD-CHO were manufactured by Merck (Rahway, NJ). Cas-
pase-3 was purified as described (Nicholson et al., 1995). PatientB, the known epitope specificity of several of the anti-
sera were used to immunoblot NuMA, PARP, and DNA-PKcs (Casci-bodies used, and the known substrate specificity of
ola-Rosen et al., 1995; Greidinger et al., 1996). In addition, twogranzyme B, these studies predict that the most likely
different monoclonal antibodies, designated 18-2 and 25±4 (kind
granzyme B cleavage site generating the 100 kDa C-ter- gifts from Tim Carter, St. Johns University, Jamaica, NY) were also
minal fragment of DNA-PKcs is VDQD3210±G3211. Simi- used to detect DNA-PKcs by immunoblotting. Rabbit polyclonal anti-
larly, a likely granzyme B cleavage site in NuMA occurs bodies to caspases were raised against the large subunits of cas-
pase-3 and caspase-7. Immunoblotted proteins were detectedat VLGD411±V412.
using the Supersignal substrate system (Pierce, Rockford, IL).Several recent studies have addressedthe cell biology
of granzyme B during perforin- or granzyme B-induced
In Vitro Cleavage of Purified DNA-PKcs andapoptosis (Froelich et al., 1996b; Trapani et al., 1996;
[35S]Methionine-Labeled Caspase-3
Shi et al., 1997). These studies demonstrated that gran- Precursor, Caspase-7 Precursor,
zyme B autonomously enters the cytoplasm of target PARP, and NuMA
cells, an event that alone does not induce target cell [35S]Methionine-labeled proteins were generated by coupled tran-
scription and translation, and cleavage reactions were performedapoptosis. In the presence of perforin, however, apopto-
in buffer consisting of 50 mM HEPES (pH 7.4), 10% sucrose, and 5sis is induced in target cells; this apoptosis is accompa-
mM dithiothreitol (Casciola-Rosen et al., 1996). After incubation atnied by the rapid enrichment of granzyme B in nuclei
378C for 15 min, reactions were terminated and samples were elec-
and nucleoli of target cells (Jans et al., 1996; Pinkoski trophoresed on 10% (DNA-PKcs and NuMA), 12% (PARP), or 15%
et al., 1996; Trapani et al., 1996). It is therefore of interest (caspases-3 and -7) SDS-polyacrylamide gels. Radiolabeled pro-
that the substrates described here, which are efficiently teins and their fragments were visualized by fluorography. Intact
and cleaved DNA-PKcs were visualized by immunoblotting withcleaved by granzyme B both in vitro and in vivo, are
monoclonal antibody 18-2 (Casciola-Rosen et al., 1995).nuclear proteins. These substrates function in both
structural and homeostatic pathways, which are af-
Calculation of Catalytic Constant Values
fected by the caspases during apoptosis. The observa- Catalytic constant (kcat/Km) values were determined using subsatu-
tion that a component of granule-induced cell death is rating substrate concentrations. Substrate and product bands on
caspase independent, taken together with the ability of autoradiograms were scanned by densitometry (PDI Discovery Sys-
tem, with Quantity One Software, Protein Databases, Huntingtoncaspases and granzyme B to efficiently cleave a com-
Station, NY), and kcat/Km values were calculated.mon subset of downstream substrates at different sites
during granule-induced cytotoxicity, highlights the im-
In Vitro Cleavage of Endogenous DNA-PKcs, NuMA,portance of proteolysis of those common substrates in
and PARP in HeLa Lysates
generating the apoptotic phenotype. In this regard, it Purified granzyme B (12.5 nM) or purified caspase-3 (105 pM) was
will be important to define the other caspase substrates added to control HeLa lysates (Casciola-Rosen et al., 1994b), in the
that are also efficiently cleaved by granzyme B. In light absence or presence of 100 nM Ac-DEVD-CHO or Ac-YVAD-CHO.
The mixtures were incubated for 15 min on ice prior to cleavageof recent descriptions of viral or endogenous caspase
reactions, performed at 378C for 60 min. After electrophoresis, theinhibitors (Beidler et al., 1995; Bump et al., 1995; Xue
intactproteins and their cleaved fragments were visualized by immu-and Horvitz, 1995; Deveraux et al., 1997; Irmler et al.,
noblotting.
1997; Srinivasula et al., 1997; Thome et al., 1997) as well
as long-lived cells or tumor cells that express low levels Determination of Granzyme B Cleavage Sites in DNA-PKcs
of specific caspase family members (Krajewska et al., by P1 Asp Mutagenesis
1997; Krajewski et al., 1997), this caspase-independent A partial cDNA clone for DNA-PKcs, encoding Met2566 through
Leu2928 (the region containing the caspase-3 cleavage site as wellactivity of granzyme B might provide the host with apo-
as the putative granzyme B site), was amplified by reverse-tran-ptotic effector mechanisms that are insensitive to inhibi-
scriptase polymerase chain reaction from HeLa cell poly(A)1 RNAtors of the signaling or execution components of the
using primers containing 59 EcoRI and 39 XbaI restriction enzyme
apoptotic cascade. adapters. After ligation into the corresponding restriction sites of
It is of interest that many of the downstream caspase pBluescript II SK1 (Stratagene), this clone was used as template
substrates described to date are autoantigens targeted for mutagenesis by overlap-extension PCR to generate clones con-
taining D2698A (P1 of the putative granzyme B site) and D2712Ain human systemic autoimmune diseases (Casciola-
Granzyme B±Mediated Cleavage of Caspase Substrates
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(P1 of the known caspase-3 site) modifications. [35S]-radiolabeled purified granzyme B were incubated for 13.5 min at 378C. Kinase
reactions were subsequently initiated by adding 100 ng SP1 and 150polypeptides were generated by coupled in vitro transcription/trans-
lation, and then incubated with either recombinant caspase-3 (8 nM) mM ATP containing 1.5 mCi [32P]ATP (3000Ci/mmol) in the absence
or presence of 10 mg/ml sheared herring sperm DNA (Promega).or granzyme B (8 nM) for 60 min at 378C in a buffer composed of
50 mM HEPES/KOH (pH 7.0), 10% (w/v) sucrose, 2 mM EDTA, 0.1% Samples were incubated at 378C for 10 min (within the linear range
of the assay; data not shown) before the reactions were terminated(w/v) CHAPS, and 5 mM dithiothreitol. The resulting cleavage prod-
ucts were resolved on SDS-polyacrylamide gels (10%±20% gradient by addition of SDS gel buffer and boiling. After electrophoresis on
8% SDS polyacrylamide gels, SP1 phosphorylation was detectedgels) and visualized by fluorography.
by autoradiography and quantitated by densitometry. Cleavage sta-
tus of the kinase was confirmed in parallel by immunoblotting (dataCleavage of Endogenous Substrates during YT Cell Granule
not shown).Content±Induced Cytotoxicity of Intact K562 Cells
YT cellgranule contentswere isolated as described(Tschopp, 1994).
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